Moreover, previous studies have shown that mast cell protease levels are significantly higher in patients with obesity, resulting in impaired glucose metabolism through the inhibition of adiponectin (Wang et al., 2011; Shi and Shi, 2012; Żelechowska et al., 2018). Here, ADIPOQ is linked to obesity disorder.